News Embecta Corp.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
14.16 ^USD	+37.88%		+38.42%	-25.20%

05-09	Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	DJ
05-09	(EMBC) EMBECTA Expects Fiscal Year 2024 EPS Range $2.20 - $2.30	MT

Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	05-09	DJ
(EMBC) EMBECTA Expects Fiscal Year 2024 EPS Range $2.20 - $2.30	05-09	MT
Earnings Flash (EMBC) EMBECTA Posts Q2 Revenue $287.2M	05-09	MT
Earnings Flash (EMBC) EMBECTA Reports Q2 EPS $0.67	05-09	MT
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results	05-09	AQ
Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024	05-09	CI
Embecta Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-09	CI
Embecta Announces Quarterly Cash Dividend	05-09	AQ
Embecta Corp. Declares Quarterly Cash Dividend, Payable on June 14, 2024	05-09	CI
Embecta to Participate in Investor Events	05-01	AQ
Embecta to Report Fiscal Second Quarter 2024 Financial Results	04-23	AQ
Embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes	03-06	AQ
Embecta Keeps Quarterly Dividend at $0.15 a Share, Payable March 15 to Shareholders as of Feb. 28	02-09	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	02-09	MT
Sector Update: Health Care	02-09	MT
Transcript : Embecta Corp., Q1 2024 Earnings Call, Feb 09, 2024	02-09
Embecta's Fiscal Q1 Adjusted Earnings Decline, Revenue Rises; Fiscal 2024 Guidance Lifted	02-09	MT
Embecta Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-09	CI
Embecta Corp. Updates Earnings Guidance for the Fiscal Year 2024	02-09	CI
(EMBC) EMBECTA Forecasts Fiscal Year 2024 EPS Range $1.95 - $2.15	02-09	MT

No results for this search